Treatment burden should be included in clinical practice guidelines

Claudia C. Dobler; Nathan Harb; Catherine A. Maguire; Carol L. Armour; Courtney Coleman; M. Hassan Murad

doi:10.1136/bmj.k4065

Treatment burden should be included in clinical practice guidelines

Claudia C. Dobler, Nathan Harb, Catherine A. Maguire, Carol L. Armour, Courtney Coleman, M. Hassan Murad

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Article number	k4065
Journal	BMJ (Online)
Volume	363
DOIs	https://doi.org/10.1136/bmj.k4065
State	Published - 2018

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/bmj.k4065

Cite this

@article{bb62cc40704e442baee71122d70efe08,

title = "Treatment burden should be included in clinical practice guidelines",

author = "Dobler, {Claudia C.} and Nathan Harb and Maguire, {Catherine A.} and Armour, {Carol L.} and Courtney Coleman and Murad, {M. Hassan}",

note = "Funding Information: High quality methods for assessing treatment burden need to be identified and meaningful ways of adding this information to clinical practice guidelines need to be explored Contributors and sources: CCD is a consultant pulmonologist. Her research focuses on evidence based medicine, knowledge translation, and medical decision making. NH is a medical student who is conducting research on the treatment burden of patients with chronic respiratory diseases. CAM balances a busy life as a tertiary education disability adviser and provisional psychologist studying her masters, mother, and wife while also spending 2-3 hours daily on treatments for her cystic fibrosis. CLA is a professor of respiratory pharmacology and director of a medical research institute and has authored more than 240 scientific publications, with a major focus on patient centred models of care. CC{\textquoteright}s role includes working with European Respiratory Society members to facilitate patient input into clinical practice guideline development. MHM has expertise in evidence based medicine, evidence synthesis, and guideline development and has authored more than 500 scientific publications (including more than 50 guidelines). CCD and MHM conceived the initial idea. CCD drafted the manuscript. All authors contributed to critical discussions of the ideas, revised the manuscript, and approved the final submission. Competing interests: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. CCD is supported by a fellowship of the National Health and Medical Research Council (APP1123733). The fellowship sponsor had no role in manuscript design, data interpretation, or writing of the manuscript. Provenance and peer review: Not commissioned; externally peer reviewed.",

year = "2018",

doi = "10.1136/bmj.k4065",

language = "English (US)",

volume = "363",

journal = "BMJ (Online)",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Treatment burden should be included in clinical practice guidelines

AU - Dobler, Claudia C.

AU - Harb, Nathan

AU - Maguire, Catherine A.

AU - Armour, Carol L.

AU - Coleman, Courtney

AU - Murad, M. Hassan

N1 - Funding Information: High quality methods for assessing treatment burden need to be identified and meaningful ways of adding this information to clinical practice guidelines need to be explored Contributors and sources: CCD is a consultant pulmonologist. Her research focuses on evidence based medicine, knowledge translation, and medical decision making. NH is a medical student who is conducting research on the treatment burden of patients with chronic respiratory diseases. CAM balances a busy life as a tertiary education disability adviser and provisional psychologist studying her masters, mother, and wife while also spending 2-3 hours daily on treatments for her cystic fibrosis. CLA is a professor of respiratory pharmacology and director of a medical research institute and has authored more than 240 scientific publications, with a major focus on patient centred models of care. CC’s role includes working with European Respiratory Society members to facilitate patient input into clinical practice guideline development. MHM has expertise in evidence based medicine, evidence synthesis, and guideline development and has authored more than 500 scientific publications (including more than 50 guidelines). CCD and MHM conceived the initial idea. CCD drafted the manuscript. All authors contributed to critical discussions of the ideas, revised the manuscript, and approved the final submission. Competing interests: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. CCD is supported by a fellowship of the National Health and Medical Research Council (APP1123733). The fellowship sponsor had no role in manuscript design, data interpretation, or writing of the manuscript. Provenance and peer review: Not commissioned; externally peer reviewed.

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85054896954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054896954&partnerID=8YFLogxK

U2 - 10.1136/bmj.k4065

DO - 10.1136/bmj.k4065

M3 - Review article

C2 - 30314981

AN - SCOPUS:85054896954

SN - 0959-8146

VL - 363

JO - BMJ (Online)

JF - BMJ (Online)

M1 - k4065

ER -

Treatment burden should be included in clinical practice guidelines

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this